Biosig Net Debt vs Other Assets Analysis

BSGM Stock

USD 2.01 0.02 0.99%

Biosig Technologies financial indicator trend analysis is way more than just evaluating Biosig Technologies prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Biosig Technologies is a good investment. Please check the relationship between Biosig Technologies Net Debt and its Other Assets accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biosig Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.

To learn how to invest in Biosig Stock, please use our How to Invest in Biosig Technologies guide.

Net Debt vs Other Assets

Net Debt vs Other Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Biosig Technologies Net Debt account and Other Assets. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Biosig Technologies' Net Debt and Other Assets is -0.03. Overlapping area represents the amount of variation of Net Debt that can explain the historical movement of Other Assets in the same time period over historical financial statements of Biosig Technologies, assuming nothing else is changed. The correlation between historical values of Biosig Technologies' Net Debt and Other Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Debt of Biosig Technologies are associated (or correlated) with its Other Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Assets has no effect on the direction of Net Debt i.e., Biosig Technologies' Net Debt and Other Assets go up and down completely randomly.

Correlation Coefficient

-0.03

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Net Debt

The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.

Other Assets

Most indicators from Biosig Technologies' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Biosig Technologies current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biosig Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.

To learn how to invest in Biosig Stock, please use our How to Invest in Biosig Technologies guide.At this time, Biosig Technologies' Issuance Of Capital Stock is very stable compared to the past year. As of the 1st of June 2024, Sales General And Administrative To Revenue is likely to grow to 1,346, while Enterprise Value Over EBITDA is likely to drop (1.31).

	2023	2024 (projected)
Extraordinary Items	2.9M	2.6M
Reconciled Depreciation	361K	232.6K

Extraordinary Items Reconciled Depreciation

Biosig Technologies fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Common Stock	Net Tangible Assets	Warrants	Accounts Payable	Other Assets	Retained Earnings Total Equity	Capital Surpluse
Total Assets		-0.08	0.24	0.33	0.99	0.46	-0.98	-0.38	0.99	0.42	0.05	0.99	0.5	0.16	0.44	0.37	0.17	1.0	0.24	0.46	0.76	-0.54	-0.27	0.09	-0.63	0.51
Short Long Term Debt Total	-0.08		-0.55	-0.5	-0.01	0.0	0.17	0.0	-0.09	0.02	0.06	-0.09	0.07	-0.02	0.0	-0.49	0.0	-0.08	0.32	0.11	-0.08	-0.03	0.1	0.08	0.02	-0.03
Other Current Liab	0.24	-0.55		0.99	0.12	0.12	-0.29	-0.31	0.25	0.09	0.03	0.26	0.42	0.32	0.31	0.96	0.22	0.24	0.08	0.1	0.35	-0.19	-0.26	-0.48	-0.3	0.33
Total Current Liabilities	0.33	-0.5	0.99		0.2	0.24	-0.35	-0.42	0.32	0.21	0.08	0.32	0.51	0.41	0.41	0.99	0.32	0.32	0.11	0.16	0.47	-0.28	-0.35	-0.4	-0.42	0.44
Total Stockholder Equity	0.99	-0.01	0.12	0.2		0.43	-0.97	-0.32	0.98	0.39	0.03	0.98	0.44	0.09	0.37	0.24	0.1	0.99	0.22	0.46	0.7	-0.51	-0.21	0.13	-0.58	0.44
Property Plant And Equipment Net	0.46	0.0	0.12	0.24	0.43		-0.31	-0.85	0.33	0.97	0.63	0.34	0.73	0.67	0.84	0.38	0.84	0.37	0.26	0.67	0.75	-0.72	-0.58	0.41	-0.89	0.83
Net Debt	-0.98	0.17	-0.29	-0.35	-0.97	-0.31		0.26	-1.0	-0.27	0.06	-1.0	-0.42	-0.07	-0.32	-0.37	-0.03	-0.99	-0.21	-0.37	-0.68	0.46	0.17	-0.03	0.52	-0.4
Retained Earnings	-0.38	0.0	-0.31	-0.42	-0.32	-0.85	0.26		-0.28	-0.81	-0.42	-0.28	-0.81	-0.94	-1.0	-0.51	-0.95	-0.31	-0.41	-0.44	-0.84	0.84	0.53	-0.24	0.95	-0.99
Cash	0.99	-0.09	0.25	0.32	0.98	0.33	-1.0	-0.28		0.29	-0.05	1.0	0.42	0.07	0.34	0.34	0.05	1.0	0.21	0.38	0.69	-0.46	-0.2	0.04	-0.53	0.41
Non Current Assets Total	0.42	0.02	0.09	0.21	0.39	0.97	-0.27	-0.81	0.29		0.78	0.29	0.69	0.63	0.8	0.34	0.81	0.33	0.27	0.75	0.72	-0.71	-0.52	0.38	-0.86	0.79
Non Currrent Assets Other	0.05	0.06	0.03	0.08	0.03	0.63	0.06	-0.42	-0.05	0.78		-0.05	0.34	0.26	0.39	0.18	0.46	-0.03	0.1	0.75	0.29	-0.32	-0.28	0.11	-0.44	0.36
Cash And Short Term Investments	0.99	-0.09	0.26	0.32	0.98	0.34	-1.0	-0.28	1.0	0.29	-0.05		0.43	0.08	0.34	0.35	0.05	1.0	0.21	0.38	0.69	-0.47	-0.2	0.04	-0.54	0.42
Common Stock Total Equity	0.5	0.07	0.42	0.51	0.44	0.73	-0.42	-0.81	0.42	0.69	0.34	0.43		0.67	0.81	0.59	0.67	0.45	0.72	0.66	0.67	-0.89	-0.14	0.16	-0.86	0.81
Common Stock Shares Outstanding	0.16	-0.02	0.32	0.41	0.09	0.67	-0.07	-0.94	0.07	0.63	0.26	0.08	0.67		0.94	0.48	0.94	0.1	0.34	0.16	0.74	-0.72	-0.51	0.23	-0.81	0.92
Other Stockholder Equity	0.44	0.0	0.31	0.41	0.37	0.84	-0.32	-1.0	0.34	0.8	0.39	0.34	0.81	0.94		0.51	0.94	0.37	0.42	0.44	0.87	-0.86	-0.53	0.24	-0.96	1.0
Total Liab	0.37	-0.49	0.96	0.99	0.24	0.38	-0.37	-0.51	0.34	0.34	0.18	0.35	0.59	0.48	0.51		0.42	0.34	0.14	0.27	0.54	-0.36	-0.41	-0.32	-0.52	0.53
Property Plant And Equipment Gross	0.17	0.0	0.22	0.32	0.1	0.84	-0.03	-0.95	0.05	0.81	0.46	0.05	0.67	0.94	0.94	0.42		0.08	0.26	0.35	0.72	-0.7	-0.62	0.3	-0.84	0.91
Total Current Assets	1.0	-0.08	0.24	0.32	0.99	0.37	-0.99	-0.31	1.0	0.33	-0.03	1.0	0.45	0.1	0.37	0.34	0.08		0.22	0.4	0.71	-0.49	-0.22	0.05	-0.56	0.44
Short Term Debt	0.24	0.32	0.08	0.11	0.22	0.26	-0.21	-0.41	0.21	0.27	0.1	0.21	0.72	0.34	0.42	0.14	0.26	0.22		0.46	0.25	-0.72	0.44	0.26	-0.45	0.41
Common Stock	0.46	0.11	0.1	0.16	0.46	0.67	-0.37	-0.44	0.38	0.75	0.75	0.38	0.66	0.16	0.44	0.27	0.35	0.4	0.46		0.39	-0.59	-0.05	0.07	-0.6	0.44
Net Tangible Assets	0.76	-0.08	0.35	0.47	0.7	0.75	-0.68	-0.84	0.69	0.72	0.29	0.69	0.67	0.74	0.87	0.54	0.72	0.71	0.25	0.39		-0.74	-0.61	0.2	-0.92	0.91
Warrants	-0.54	-0.03	-0.19	-0.28	-0.51	-0.72	0.46	0.84	-0.46	-0.71	-0.32	-0.47	-0.89	-0.72	-0.86	-0.36	-0.7	-0.49	-0.72	-0.59	-0.74		0.08	-0.39	0.89	-0.86
Accounts Payable	-0.27	0.1	-0.26	-0.35	-0.21	-0.58	0.17	0.53	-0.2	-0.52	-0.28	-0.2	-0.14	-0.51	-0.53	-0.41	-0.62	-0.22	0.44	-0.05	-0.61	0.08		0.02	0.48	-0.53
Other Assets	0.09	0.08	-0.48	-0.4	0.13	0.41	-0.03	-0.24	0.04	0.38	0.11	0.04	0.16	0.23	0.24	-0.32	0.3	0.05	0.26	0.07	0.2	-0.39	0.02		-0.25	0.25
Retained Earnings Total Equity	-0.63	0.02	-0.3	-0.42	-0.58	-0.89	0.52	0.95	-0.53	-0.86	-0.44	-0.54	-0.86	-0.81	-0.96	-0.52	-0.84	-0.56	-0.45	-0.6	-0.92	0.89	0.48	-0.25		-0.97
Capital Surpluse	0.51	-0.03	0.33	0.44	0.44	0.83	-0.4	-0.99	0.41	0.79	0.36	0.42	0.81	0.92	1.0	0.53	0.91	0.44	0.41	0.44	0.91	-0.86	-0.53	0.25	-0.97

Click cells to compare fundamentals

Biosig Technologies Account Relationship Matchups

Biosig Technologies fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	14.2M	30.4M	15.5M	4.1M	1.8M	1.7M
Other Current Liab	1.6M	4.8M	2.3M	2.9M	4.2M	3.0M
Total Current Liabilities	2.0M	5.1M	2.6M	3.3M	4.6M	3.2M
Total Stockholder Equity	11.4M	24.5M	12.3M	418K	(2.9M)	(2.8M)
Property Plant And Equipment Net	894.7K	595.0K	1.3M	1.5M	938K	531.7K
Net Debt	(11.4M)	(28.0M)	(11.0M)	408K	262K	275.1K
Retained Earnings	(104.8M)	(157.0M)	(188.9M)	(216.0M)	(245.0M)	(232.8M)
Cash	12.1M	28.3M	11.7M	357K	190K	180.5K
Non Current Assets Total	1.4M	1.0M	1.6M	3.0M	1.3M	890.5K
Non Currrent Assets Other	129.2K	107K	42K	1.2M	43K	40.9K
Cash And Short Term Investments	12.1M	28.3M	11.7M	458K	293K	278.4K
Common Stock Total Equity	29.3K	16.9K	23.3K	31K	35.7K	21.9K
Common Stock Shares Outstanding	2.1M	2.8M	3.4M	4.3M	7.4M	7.7M
Liabilities And Stockholders Equity	14.2M	30.4M	15.5M	4.1M	1.8M	1.7M
Other Stockholder Equity	115.9M	181.3M	201.1M	216.2M	242.1M	254.2M
Total Liab	2.3M	5.1M	3.0M	3.7M	4.7M	3.4M
Property Plant And Equipment Gross	894.7K	595.0K	1.8M	2.4M	2.5M	2.6M
Total Current Assets	12.8M	29.3M	13.9M	1.1M	528K	501.6K
Common Stock	23.3K	31K	36K	55K	9K	8.6K
Net Tangible Assets	3.1M	10.8M	24.0M	11.9M	13.7M	14.4M
Warrants	985K	475K	215K	105K	94.5K	89.8K
Accounts Payable	346.2K	30K	1K	2.9K	2.6K	2.4K
Other Assets	54.2K	129K	(44.0)	42K	48.3K	44.3K
Retained Earnings Total Equity	(56.5M)	(70.7M)	(104.8M)	(157.0M)	(141.3M)	(134.2M)
Capital Surpluse	53.2M	74.0M	115.9M	181.3M	208.5M	219.0M
Other Current Assets	141.2K	301K	354K	325.0	314K	181.2K
Property Plant Equipment	44.3K	894K	595K	1.3M	1.4M	1.5M
Non Current Liabilities Total	311.1K	1K	378K	452K	103K	175.3K
Net Invested Capital	11.1M	24.4M	12.2M	313K	(3.0M)	(2.9M)
Net Working Capital	10.8M	24.2M	11.3M	(2.1M)	(4.1M)	(3.9M)
Capital Stock	238.3K	136K	141K	160K	114K	170.8K
Intangible Assets	365.7K	347K	327K	308K	289K	254.2K

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Biosig Technologies using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Fix portfolios for free

When determining whether Biosig Technologies is a strong investment it is important to analyze Biosig Technologies' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Biosig Technologies' future performance. For an informed investment choice regarding Biosig Stock, refer to the following important reports:

How To Invest In Biosig

Details

Is Biosig Stock a good investment?

Details

What is Biosig Technologies' Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biosig Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.

To learn how to invest in Biosig Stock, please use our How to Invest in Biosig Technologies guide.

Note that the Biosig Technologies information on this page should be used as a complementary analysis to other Biosig Technologies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Complementary Tools for Biosig Stock analysis

When running Biosig Technologies' price analysis, check to measure Biosig Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biosig Technologies is operating at the current time. Most of Biosig Technologies' value examination focuses on studying past and present price action to predict the probability of Biosig Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biosig Technologies' price. Additionally, you may evaluate how the addition of Biosig Technologies to your portfolios can decrease your overall portfolio volatility.

	Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
	Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital
	Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
	Content Syndication Quickly integrate customizable finance content to your own investment portal
	Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
	Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities
	Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios
	Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
	Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format

Is Biosig Technologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biosig Technologies. If investors know Biosig will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biosig Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(3.12)

Revenue Per Share

0.003

Quarterly Revenue Growth

1.8

Return On Assets

(4.48)

Return On Equity

(59.77)

The market value of Biosig Technologies is measured differently than its book value, which is the value of Biosig that is recorded on the company's balance sheet. Investors also form their own opinion of Biosig Technologies' value that differs from its market value or its book value, called intrinsic value, which is Biosig Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biosig Technologies' market value can be influenced by many factors that don't directly affect Biosig Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Biosig Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Biosig Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biosig Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Biosig Net Debt vs Other Assets Analysis

Net Debt vs Other Assets

Net Debt vs Other Assets Correlation Analysis

Correlation Coefficient

Net Debt

Other Assets

Biosig Technologies fundamental ratios Correlations

Biosig Technologies Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Biosig Technologies fundamental ratios Accounts

Becoming a Better Investor with Macroaxis

Build Optimal Portfolios

Align your risk with return expectations

Complementary Tools for Biosig Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash And Short Term Investments
Capital Surpluse	+ 1.0	Other Stockholder Equity
Total Stockholder Equity	+ 0.99	Total Assets

Other Stockholder Equity	- 1.0	Retained Earnings
Cash And Short Term Investments	- 1.0	Net Debt
Cash	- 1.0	Net Debt
Capital Surpluse	- 0.99	Retained Earnings
Total Current Assets	- 0.99	Net Debt
Net Debt	- 0.98	Total Assets